This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
ADVIA CENTAUR ENHANCED ESTRADIOL (2016-01-14)
- Starting date:
- January 14, 2016
- Posting date:
- January 25, 2016
- Type of communication:
- Medical Device Recall
- Subcategory:
- Medical Device
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Medical Devices
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-56820
Affected Products
- ADVIA CENTAUR ENHANCED ESTRADIOL
- ADVIA CENTAUR CP SYSTEM ENHANCED ESTRADIOL
Reason
Siemens Healthcare Diagnostics is conducting a correction for all lots of ADVIA Centaur Enhanced Estradiol, Dimension Vista LOCI Estradiol, IMMULITE/IMMULITE 1000 Estradiol and IMMULITE 2000 Estradiol. Siemens has confirmed the drug fulvestrant (FASLODEX) may cause falsely elevated estradiol results in the assays listed.
Affected products
A. ADVIA CENTAUR ENHANCED ESTRADIOL
Lot or serial number
ALL
Model or catalog number
- 10490889
- 10491445
Companies
- Manufacturer
-
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES
B. ADVIA CENTAUR CP SYSTEM ENHANCED ESTRADIOL
Lot or serial number
ALL
Model or catalog number
- 10490889
- 10491445
Companies
- Manufacturer
-
Siemens Healthcare Diagnostics Inc.
511 Benedict Ave
Tarrytown
10591
New York
UNITED STATES